Former Assistant District Attorney Indicted on Bribery, Money[...]
Baseline characteristics for INFRONT 3: A Phase 3 double blind, placebo[...]
05/04/2022 | Press release | Distributed by Public on 05/04/2022 08:15
Please select the service you want to use:
Smartlinks | e-Therapeutics plc | News | Health | Science | Biology | Company News | Top Company News | Shareholder Meeting | Company Appointments | Board Change | Pharmaceuticals | Public Companies | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | Börse Frankfurt | Börse Berlin | Börse Stuttgart | OTC Markets | Cboe Off Exchange
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact